Study shows why crossing obstacles is difficult for patients with Parkinson’s disease
Heart failure and stroke rising in men under 40
8 April 2021Understanding and addressing barriers to COVID vaccine acceptance
8 April 2021Study shows why crossing obstacles is difficult for patients with Parkinson’s disease
A multidisciplinary research group affiliated with the Department of Physical Education’s Human Movement Laboratory (Movi-Lab) at São Paulo State University (UNESP) in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson’s disease and concluded that it was 53% lower than in healthy subjects of the same age and weight. Step length is one of the main variables affected by the disease.
